According to the research report "Global Diabetes Management Supplements Market Outlook, 2030," published by Bonafide Research, the Global Diabetes Management Supplements market was valued at more than USD 7.82 Billion in 2024, and expected to reach a market size of more than USD 12.60 Billion by 2030 with the CAGR of 8.46% from 2025-2030

Top Six Companies Global Diabetes Management Supplements Market

Herbalife Nutrition Ltd: Herbalife Nutrition Ltd., also called Herbalife International, Inc. or simply Herbalife, is an American multinational multi-level marketing corporation that develops and sells dietary supplements. Herbalife Ltd. is a premier global health and wellness company, founded in 1980. It specializes in science-backed nutritional supplements, weight-management products, and personal care. Operating in over 94 countries, it utilizes a direct-selling model through independent distributors who offer personalized coaching and wellness communities. Herbalife Nutrition Ltd. has a presence in the diabetes management supplements space mainly through its nutrition, weight management, protein, meal replacement, and targeted wellness product portfolio rather than as a dedicated diabetes drug or clinical diabetes-treatment company. The company offers products such as meal replacement shakes, protein supplements, fiber-based nutrition, vitamins, and targeted nutrition products that can support weight control, balanced diet planning, and healthy lifestyle routines, which are important areas for people managing diabetes or prediabetes. Herbalife also positions its distributor-led coaching model as part of a broader wellness ecosystem, and its Lifestyle Intervention Program received CDC recognition as a certified diabetes prevention program in 2023.

• Established: 1980

• Headquarters: California, United States

• Employees: 10,000+

• Revenue: USD 5,037 Million

Amway Corp: Amway Corp (Amway), a subsidiary of Alticor Global Holdings Inc, is a manufacturer, retails and distributes nutrition, beauty and body and bath products. The company’s product portfolio includes skin care, personal care, home care, health and beauty, and nutrition products that includes surface cleaners, disinfectant cleaners, dish detergents, toners, moisturizers, eye, and lip care products, serums, and makeup products. Amway Corp. participates in the diabetes management supplements market through its Nutrilite nutrition and wellness portfolio, especially products positioned around healthy glucose metabolism, weight management, balanced nutrition, and plant-based supplementation. The company offers products such as Nutrilite Glucose Health, which is marketed to help support metabolism and maintain already-normal glucose levels, along with nutrition products such as meal replacements, protein supplements, vitamins, minerals, and weight-management solutions that may support lifestyle-based diabetes risk management. In some markets, Amway also offers herbal or botanical products such as Madhunashini, Shunti & Twak and botanical beverages with ingredients like fenugreek, cinnamon, mulberry, and other plant extracts associated with glucose-management positioning. However, Amway’s products should be viewed as dietary and lifestyle-support supplements, not as medicines or substitutes for diabetes treatment, and the company’s product disclaimers indicate that such supplements are not intended to diagnose, treat, cure, or prevent disease.

• Established: 1959

• Headquarters: Michigan, United States

• Employees: 14,000

• Revenue: USD 7,300 Million

Abbott Laboratories: Abbott Laboratories has a strong presence in the diabetes management supplements and specialized nutrition market through its Glucerna brand, which is specifically formulated for people with diabetes, prediabetes, gestational diabetes, or those requiring glycemic management. Glucerna products include shakes, powders, and nutritional drinks designed with low-glycemic and slow-release carbohydrate blends such as CARBSTEADY, which help minimize blood sugar spikes compared with high-glycemic carbohydrates. Abbott also markets Ensure Diabetes Care in some countries, offering balanced nutrition with protein, fiber, vitamins, minerals, and low-GI carbohydrates for people managing blood sugar through diet and lifestyle. The company’s diabetes nutrition products are positioned as part of a broader diabetes management plan involving diet, exercise, and medical supervision, rather than as medicines or substitutes for prescribed diabetes treatment. Therefore, Abbott Laboratories is one of the leading players in the diabetes management supplements market, supported by its medical nutrition expertise, global brand recognition, and clinically positioned diabetes-focused nutrition portfolio.

• Established: 1888

• Headquarters: Illinois, United States

• Employees: 122,000

• Revenue: USD 44,328 Million

Nestlé Health Science S.A: Nestlé Health Science S.A. has a strong position in the diabetes management supplements market through its specialized medical nutrition and oral nutritional supplement portfolio, including products such as BOOST Glucose Control, Resource Diabetic, and Nutren Diabetes. These products are formulated for people with diabetes, impaired glucose tolerance, or those concerned about blood sugar management, using low-glycemic carbohydrate blends, balanced protein, fiber, vitamins, and minerals to support dietary glucose control as part of a medically supervised plan. BOOST Glucose Control is designed for people with diabetes and is clinically shown to produce a lower blood sugar response compared with a standard nutritional drink in people with type 2 diabetes, while Nutren Diabetes and Resource Diabetic are positioned as low-GI, nutritionally balanced formulas for dietary management and nutrition support. However, these products are not substitutes for diabetes medication or medical treatment. Therefore, Nestlé Health Science is best positioned as a medical nutrition and diabetes-specific dietary supplement player in the diabetes management supplements market.

• Established: 2011

• Headquarters: Vevey, Switzerland

• Employees: 11,000

• Revenue: USD 111,238 Million

NOW Foods: NOW Foods participates in the diabetes management supplements market through its Glucose Management supplement category, which includes products positioned for blood sugar and glucose metabolism support. Its portfolio includes supplements such as Glucose Metabolic Support, which contains GlucoFit® and Gymnema sylvestre extract; Berberine Glucose Support, which supports already-normal glucose and lipid metabolism; and Tri-Chromium with Cinnamon, which is positioned for blood sugar support already within the normal range. The company also promotes glucose management as part of a broader healthy lifestyle approach that includes diet and exercise, rather than as a replacement for medical diabetes treatment. Therefore, NOW Foods can be positioned as a natural supplements and glucose-metabolism support player in the diabetes management supplements market, with emphasis on botanical ingredients, minerals, and condition-specific wellness products.

• Established: 1968

• Headquarters: Illinois, United States

• Employees: 1,500

• Revenue: Estimated USD 438.8 Million

Glanbia plc: Glanbia plc participates in the diabetes management supplements market mainly through its lifestyle nutrition, protein, low-sugar snacking, and nutrition-ingredient capabilities, rather than through a dedicated diabetes-specific medical nutrition brand like Glucerna or BOOST Glucose Control. The company’s Glanbia Performance Nutrition portfolio includes brands such as Optimum Nutrition, Isopure, think!, BSN, Nutramino, and Amazing Grass, which are positioned around active lifestyle, protein intake, weight management, and healthier snacking. Its think! products include high-protein, low-sugar bars, while Isopure offers low-carb and zero-sugar protein nutrition, making these products relevant for consumers seeking lower-sugar dietary options as part of glucose-conscious nutrition. Glanbia also supports food and supplement manufacturers through its nutrition ingredients business, which can be used in formulations targeting protein enrichment, weight management, and metabolic wellness. However, Glanbia should be positioned as an indirect diabetes management supplements player, focused on protein, low-sugar nutrition, weight-management support, and functional ingredients, not as a company offering diabetes-treatment products or disease-specific therapeutic supplements.

• Established: 1997

• Headquarters: Kilkenny, Ireland

• Employees: 5,800

• Revenue: USD 3,900 Million